INTRODUCTION
Chromatin condensation is modified by altering the charges on histone tails. By changing the balance of charges surrounding a gene, it may activate or repress transcription. This process depends on the type, extent, and location of histone modifications. Histone methylation occurs on lysine (K) and arginine (R) residues. Methylation at K can be either mono-(me1), di-(me2) or tri-(me3); while histone R methylation can be mono-or di-, and the latter either symmetrical or asymmetrical (1) . In general, trimethylation and dimethylation of histone 3 K4 (H3K4), H3K36 and H3K79 are located in euchromatic regions that are transcriptionally active, whereas trimethylation and dimethylation of H3K9, H4K20 and H3K27 are associated with transcriptionally silenced heterochromatin (2) . Methylation of H3K9 is catalyzed by SET-domain containing histone lysine methyltransferases (HMTs) (3) , and methyl groups are removed by histone lysine demethylases (KDMs) (4) . The KDM1 family and Jumonji C (JmjC) domain-containing KDMs are the two major families of KDMs (5, 6) . JmjC domaincontaining KDMs can be further classified into different groups based on their sequence homology and demethylase activities (7) . Several KDMs are essential for development, and their dysregulation is associated with human diseases including cancer (8) . For example, KDM4A and KDM4C regulate the transition of mouse embryonic stem cells to endothelial lineage (9) , although KDM4A and KDM4C may appear to be dispensable in mouse embryonic development (10, 11) . Continual removal of H3K9 promoter methylation by KDM4 demethylases is vital for ESC self-renewal and early development (11) . In spite of cumulative evidence, whether KDMs are involved in immune cell development and differentiation, such as B cell activation and differentiation, remains unclear.
Engagement of the B cell receptor (BCR) with an antigen triggers B cell activation and proliferation, thereafter inducing the differentiation of antigen-specific antibodysecreting plasma cells (12) . Specialized T follicular helper (Tfh) cells located in the germinal centers (GCs) of secondary lymphoid organs promote the activation, proliferation and differentiation of B cells by providing IL-21 and CD40 ligand (13, 14) . Whether and how epigenetic programming is involved in the regulation of Tfh signalsmediated B cell activation is largely unknown.
We here found that following activation with Tfh cellmimicking signals, B cells experience a KDM4A/KDM4C-mediated global down-regulation of H3K9me2/me3 in vitro. Further mapping of KDM4A/KDM4C targets using chromatin immunoprecipitation (ChIP) assays with sequencing (ChIP-seq) revealed that the WD40-repeat protein, WDR5, is important for decelerating the proliferation of activated B cells. Uncontrolled B cell activation coupled with abnormal cell cycle regulation has been linked with the pathogenesis of B cells in autoimmune diseases (15) . We also demonstrate that the KDM4A/KDM4C-mediated epigenetic change, induced by Tfh-derived signals, is perturbed in activated B cells isolated from systemic lupus erythematosus (SLE) patients.
MATERIALS AND METHODS

Mice and cell cultures
MD4 transgenic mice expressing the B cell receptor with specificity for HEL in a C57BL/6 background and Prdm1 EYFP/+ reporter mice were purchased from The Jackson Laboratory and maintained under specific pathogen free conditions in the animal facility of the Institute of Cellular and Organismic Biology at Academia Sinica. Mouse splenic B220 + B cells from mouse splenocytes were isolated by magnetic sorting with CD45R (B220) microbeads (Miltenyi Biotec) as previously described (16) . The purified B220 + B cells were stimulated with antimouse CD40 (1 g/ml, BD Pharmingen), IL-21 (100 ng/ml, eBioscience), and HEL (1 g/ml, Sigma-Aldrich) or LPS (2.5 g/ml, Sigma-Aldrich). Prdm1 EYFP/+ reporter mice were immunized i.p. with 100 g (4-hydroxy-3-nitrophenyl) acetyl (NP) 25 -keyhole limpet hemocyanin (KLH) (Biosearch Technologies) in the primary and secondary immunizations (6 weeks apart). All animal experiments were approved by the Institutional Animal Care and Utilization Committee of Academia Sinica. Venous blood samples from SLE patients and normal healthy donors were acquired from the National Taiwan University Hospital, the Taipei Tzu Chi Hospital and the Taipei Blood Center. Patient consent procedures were approved by the National Taiwan University Hospital, Taipei Tzu Chi Hospital and Academia Sinica Research Ethics Committee. Peripheral blood B cells from SLE patients or healthy donors were purified as previously descried (16) . Purified human CD19 + B cells were stimulated with 10 ng/ml anti-human CD40 (R&D Systems), 200 ng/ml IL-21 (R&D Systems), 50 ng/ml BAFF (PeproTech) and 5 g/ml anti-human IgM (Jackson ImmunoResearch). Where required, B cells were treated with 200 M 8-hydroxyquinoline (8-HQ; EMD Millipore) or with 15 M NF-B inhibitor (Bay 11-7082, Calbiochem).
Lentiviral transduction and siRNA transfection
The preparation of lentiviral vectors was described previously (16) . cDNA encoding WDR5 was cloned into a lentiviral vector, pFUGW (17) . The detailed cloning procedures will be available upon request. B220 + cells were transduced with concentrated lentiviral vectors at M.O.I. = 10 in the presence of polybrene (5 g/ml, Sigma).
The small interfering RNA (siRNA) sets for knocking down the expression of specific genes were purchased from Integrated DNA technologies . The target sense  sequences of mouse FAM-tagged KDM4A siRNA are:  5 -UCUAUACAGCAUCAACUAUCUGCAC-3 and  5 -GGCAAUUCUAGAAGCAAGGUUUGTC-3 ;  of mouse FAM tagged-KDM4C siRNA are 5  GGUAGCGAGUGAUGAAGAAUUGCCT-3  and  5 -GGAUACAAGUGGAUCAAAGCUUACT-3 .  FAM-tagged  WDR5  siRNA  sequences  are:  5 -AUAAUAAGAAUCCAAAGGUAUUGGA-3 ,  5 -ACCGUGAUGGAUCAUUGAUUGUUTC-3 , and 5 -CAAGUUCAUCUGCUGAUAAACUCAT-3 .
Flow cytometric analysis
Cell surface molecules were stained by resuspending 5 × 10 5 B cells in 50 l FACS staining buffer containing 0.1% NaN 3 , 1% FCS in 1 × PBS and various fluorochromeconjugated antigen-specific antibodies at 4
• C for 15 min, followed by washing with 0.5 ml FACS staining buffer twice. 5-bromo-2 -deoxyuridine (BrdU) incorporation assay with APC-conjugated anti-BrdU (clone 3D4, 1mM, BD Pharmingen) was performed according to the manufacturer's suggestions. PKH26 cell proliferation assay is preformed according to the user's instructions of PKH26 Red Fluorescent Cell Linker Kits (Sigma-Aldrich). Final concentration of PKH26 at 2 M was used for staining. Antibodies, all purchased from BD Pharmingen, in this study are: APC-conjugated anti-mouse CD69 (clone H1.2F3), APC-conjugated anti-mouse CD86 (clone GL1), APCconjugated mouse B220 (clone RA3-6B2), PE-conjugated anti-mouse CD138 (clone 281-2), APC-conjugated antihuman CD69 (clone FN50), APC-conjugated anti-human CD86 (clone IT2.2), PE-conjugated anti-human IgD (clone IA6-2) and APC-conjugated anti-human CD38 (clone HB7). The fluorescence intensity was detected with FACSCanto (Becton Dickinson) flow cytometry and analyzed by the FlowJo software.
RNA isolation and RT-qPCR analysis
Total RNA was prepared from stimulated mouse splenic B220 + B cells or human peripheral CD19 + B cells with RNeasy Mini Kit (Qiagen). The cDNA was further synthesized by High-Capacity cDNA Reverse Transcription Kits (Thermo Fisher Scientific) with random primer mix. The cDNA was quantified by qPCR5 -CTTTGCCACAAGAACCATCTGGG-3 and 5 -GCCAAAGTTGGAGTCCATTCGG-3 , and ACTB: 5 -CACCATTGGCAATGAGCGGTTC-3 and 5 -AGGTCTTTGCGGATGTCCACGT-3 .
Immunoblot analysis and immunoprecipitation
Pre-cleared nuclear extracts or total cell extracts were prepared according to a previous protocol (18) . Immunoprecipitation was performed as previously descried (18) , by using pre-cleared nuclear extracts. 50 g of nuclear extracts from various samples were incubated with 2 g of anti-KDM4A (Abcam) or anti-KDM4C antibodies (Abcam) at 4
• C for overnight and then reacting with protein A/Gsepharose (Santa Cruz Biotechnology) for 3 h. Immunoblot analysis was performed essentially following previously published protocols (18) . Primary antibodies, all purchased from Abcam unless otherwise indicated, are: antiH3K9me2 (1:500), anti-H3K9me3 (1:500), anti-H3K4me1 Chromatin immunoprecipitation assay (ChIP) and sequential chromatin ommunoprecipitation assay (re-ChIP) 10 7 stimulated mouse B220 + B cells were used per immunoprecipitation. The protein-chromatin complexes were purified by immunoaffinity captured by magnetic beads (Thermo Fisher Scientific). The enriched DNA was subjected to qPCR or deep sequencing. The re-ChIP assay was performed by using 2 × 10 7 stimulated B220 + B cells in the first ChIP. The immunoprecipitated chromatin complexes from the first ChIP assay were eluted by DTTcontaining elution Buffer (10 mM DTT, 0.2% SDS in 1 × TE buffer) for 30 min at 37
• C and then were further diluted 20-fold in a dilution buffer (10 mM Tris-HCl, pH8.0, 1 mM EDTA, 0.5 M EGTA, 100 mM NaCl, 1% Triton X-100 and protease inhibitor cocktail 
ChIP-seq
ChIP-seq libraries were prepared using standard protocols provided by Illumina (www.illumina.com). Libraries were sequenced (Solexa, Illumina) in two successive runs and output from each sample was used for analysis. The resulting sequence outputs (bases 2-42) were aligned to the ref-erence mouse genome (version mm9) using bowtie 0.12.7 (19) .
The peaks were filtered for P < 10 −20 , next, peak calling and annotation were done by using Model-based Analysis of ChIP-Seq (MACS, version 1.4) (20) and peakAnnotator (version 1.4) (21), respectively. The published ChIPseq data from Gene Expression Omnibus (GEO) database were acquired to analyze the binding targets of H3K9me2 and H3K9me3 (accession number GSE82144) (22) , RELA (GSE36099) (23) , and KDM4A and KDM4C in mouse acute myeloid leukemia (AML) cells (GSE81300) (24) .
Motif discovery
For de novo motif prediction analysis of ChIP-seq results, HOMER motif analysis software (25) was used to identify among the KDM4A/KDM4C binding regions overrepresented DNA sequence motifs. From the summit of the ChIP-seq binding peak, we extended the genomic region by 500 bp on either side to obtain a 1000-bp region, to be scanned for over-represented DNA sequence motifs. The over-represented DNA motif-sequences were compared with known motifs of transcription factors.
Microarray and gene ontology (GO) analysis
Total RNA from 10 7 stimulated mouse B220 + B cells was extracted with TRIzol reagent (Thermo Fisher Scientific) according to the manufacturer's instructions. Approximately 2 g of RNA was labeled and hybridized to GeneChip Mouse Genome 430 2.0 arrays (Affymetrix) according to the manufacturer's protocols. All data analysis was performed using GeneSpring software GX 7.3.1 (Agilent Technologies). GO analysis of differentially expressed genes was performed using the Biological Networks Gene Ontology (BiNGO) program package with P ≤ 0.05 (26) . The ten most significant terms in the Biological Process ontology were selected to show the functional characteristics of the given gene sets.
Statistical analysis
Statistical analysis was performed based on a two-tailed t test. P < 0.5 was considered statistically significant.
RESULTS
Induction of KDM4A and KDM4C is associated with downregulation of H3K9me2/me3 in B cells after exposure to Tfh cell-derived signals
We first examined the expression of various histone markers and histone modifying enzymes in mouse splenic B cells exposed to Tfh cell-derived signals. Primary splenic B cells isolated from MD4 transgenic mice that carry the BCR with specificity for hen egg lysozyme (HEL; (27) ) were stimulated with IL-21, anti-CD40 and HEL, to mimic the exposure of Tfh cell-derived signals in antigen-primed B cell responses (13, 14) . Remarkably, immunoblotting using nuclear extracts and a panel of antibodies specific for acetylation (ac), me2 or me3 at K4, K9, K27 and K36 of H3 revealed that global H3K9me2/me3 and H3K36me2/me3 levels start to decline 24 h after stimulation ( Figure 1A ) and remain downregulated at 48 h. Other histone markers did not change substantially ( Figure 1A ) and similar results were found when histone extracts were used instead (Supplementary Figure S1A) . To determine whether the decreased histone methylation is a result of up-regulation of KDMs, we examined KDM expression in splenic B cells treated with Tfh cell-mimicking stimuli. Among those examined, mRNA levels of Kdm4a and Kdm4c which encode demethyalses specific for H3K9me2/me3 and H3K36me2/me3, were most significantly up-regulated from 18 h after stimulation ( Figure 1B and Supplementary Figure S1B) . Accordingly, KDM4A and KDM4C protein levels were dramatically increased ( Figure 1C ) and were inversely associated with the reduced H3K9me2/me3 and H3K36me2/me3 levels. However, activation of B cells by lipopolysaccharide (LPS) treatment neither substantially up-regulated KDM4A and KDM4C nor caused reduction of H3K9me2/me3 (Figure 1D ). Moreover, reduced global H3K9me2/me3 and H3K36me2/me3 levels and induction of KDM4A and KDM4C were not limited to stimulation with the BCRspecific antigen, HEL; similar expression patterns were observed when anti-IgM was applied to ligate the BCR together with IL-21 and anti-CD40 treatment (Supplementary Figure S1C and D). Kdm3b was also up-regulated substantially in B cells responding to Tfh-mediated signals (Supplementary Figure S1B) . However, because KDM3B demethylases H3K9me2/me1 (28), which is not detected by our antibody panel, we chose to focus on KDM4A and KDM4C in this study. Also, given that KDM4-dependent control of H3K9me3 levels at gene promoters is crucial for transcriptional activity (11), we hereafter focus on the effects of the connection between KDM4A/KDM4C and H3K9me2/me3 on B cell activation. Together, we show that global H3K9me3 levels are decreased in activated B cells exposed to Tfh-cell mimicking signals in vitro.
Depletion of KDM4A and KDM4C prolongs B cell activation and proliferation
We next sought to investigate the functional effects of KDM4A and KDM4C on B cells stimulated with Tfh-cell mimicking signals. Transfection of siRNA-pools against Kdm4a and Kdm4c into mouse splenic B cells after stimulation largely blocked the reduction of H3K9me2/me3, as compared with cells transfected with control siRNA carrying scramble sequence (siCtrl; Figure 2A ). The upregulation kinetics of surface CD69 and CD86 was prolonged in siKDM4A-or siKDM4C-transfected cells (Figure 2B and C). CD69 and CD86 levels peaked at 18 and 24 h, respectively, after stimulation of siCtrl-transfected cells. In contrast, CD69 and CD86 levels on siKDM4A-or siKDM4C-transfected cells were sustained at high levels at 48 h. In addition, the abundances of BrdU positive cells were increased in KDM4A-and KDM4C-depleted cells at 24, 36 and 48 h after stimulation, as compared those in siCtrl-transfected cells ( Figure 2D ). The enhanced B cell activation and proliferation may not result from the offtarget effects of siRNA-pools because two individual siRNAs against Kdm4a and Kdm4c also give rise to similar results (Supplementary Figure S2) . Combined, these data suggest that depletion of KDM4A or KDM4C results in prolonged B cell activation and enhanced B cell proliferation in response to signals derived from Tfh cells.
KDM4A and KDM4C associate with NF-B in activated B cells
Given that KDM4A and KDM4C lack site-specific DNA binding capacities, we next sought to identify the transcription factors that collaborate with KDM4A or KDM4C to regulate the activation and proliferation of B cells when encountering Tfh cell-mimicking signals. Toward this end, we performed ChIP-seq to profile the genome-wide binding of KDM4A and KDM4C in splenic B cells stimulated with Tfh-mimicking signals. Analysis of the common peak sequences of KDM4A and KDM4C from ChIP-seq data with de novo motif discovery programs identified a KDM4A and KDM4C binding motif ( Figure 3A ). This motif found in the vicinity of KDM4A and KDM4C-specific peaks shares the known motifs with transcription factors TEA domain transcription factor 4 (TEAD4), TEAD3 and NF-B p65 (RELA) ( Figure 3B ). However, given that TEAD4 and TEAD3 binding sites resemble to the NF-B site (29) , and that NF-B is critical for activation and proliferation of B cells, we chose to examine the involvement of NF-B on the effects of KDM4A and KDM4C during Tfh cell-mimicking signals-mediated B cell activation.
Nuclear extracts isolated from mouse splenic B cells treated with Tfh cell-mimicking stimuli for 0, 24 and 48 h were subjected to co-immunoprecipitation (co-IP) to examine the interaction of NF-B p65 and KDM4A or KDM4C. KDM4A and KDM4C form a complex at 24 and 48 h after stimulation because either one of them can be immunoprecipitated by an antibody against the other ( Figure 3C ). Notably, NF-B p65 can be detected in anti-KDM4A and anti-KDM4C immunoprecipitates 24 h after stimulation ( Figure  3D ). However, the interaction between KDM4A, KDM4C and NF-B p65 is reduced at 48 h, despite them all being expressed in the nucleus ( Figure 3C ). Next, a sub-optimal dose of the NF-B inhibitor, Bay 11-7082 was used to treat stimulated B cells, which is thought to bypass the cytotoxicity effects caused by the complete blockage of NF-B activation. Remarkably, the global reduction of H3K9me2/me3 after B cell stimulation was largely rescued in the presence of NF-B inhibitor as compared with those in solvent control DMSO-treated cells ( Figure 3D ). These results suggest that temporal association of KDM4A, KDM4C and NF-B cooperatively establishes the global changes in H3K9me2/me3 following activation of B cells.
Genome-wide analysis identifies
Wdr5 as the KDM4A/KDM4C target in activated B cells KDM4A and KDM4C target loci were mapped by computational analysis of ChIP-seq data. We obtained approximate 5 million uniquely aligned reads and further used model-based analysis of ChIP-seq (MACS) to identify 1187 KDM4A-bound regions and 1240 KDM4C-bound regions in activated B cells (Supplementary Table S1 ). Most of the KDM4A-and KDM4C-bound regions were distal and intergenic regions, but some were annotated to 246 and 264 genes (Supplementary Table S2 ), respectively. Interestingly, a large proportion of targets are co-occupied by both KDM4A and KDM4C; 68.3% of KDM4A peaks overlapped with 63.6% of KDM4C peaks in activated B cells (Figure 4A ), supporting the hypothesis that KDM4A and KDM4C elicit their effects as a protein complex.
Gene expression profiles in KDM4A-and KDM4C-depleted B cells stimulated with Tfh cell-mimicking signals for 0, 24 and 72 h were investigated using microarray analysis. Genes showing at least 1.5-fold up-or down-regulation in KDM4A and KDM4C knockdown cells after stimulation are listed in Supplementary Table S3 . Among these genes, Wdr5 is a core subunit of the SET1/MLL or COM-PASS complexes that facilitates the assembly and activity of complexes (30) , but the role of WDR5 in B cells is unknown. We observed KDM4A and KDM4C binding in broad genomic regions 5 distal to Wdr5 ( Figure 4B ). These results were further validated by an independent ChIP experiment ( Figure 4C ). Further combined analysis of the previously published ChIP-seq data of histone marks of activated B cells (22) showed that the distribution of H3K9me2 and H3K9me3 was predominantly located at the region upstream of Wdr5 and their enriched peaks were decreased after stimulation ( Figure 4B ).
More importantly, KDM4A and KDM4C are required for the up-regulation of Wdr5, as knocking down the expression of KDM4A or KDM4C dramatically blocked Wdr5 induction after stimulation as compared with siCtrl transfected B cells ( Figure 4D ). This effect was associated with the increased levels of H3K9me2/me3 on Wdr5 in KDM4A or KDM4C knockdown B cells (Figure 4E) . Given that KDM4A, KDM4C and NF-B p65 form a complex, we next examined whether NF-B p65 also participates in the regulation of Wdr5. Our sequential ChIP (re-ChIP) assay using either anti-p65 or control rabbit IgG (rIgG) in the first ChIP and then anti-KDM4A, anti-KDM4C, or rIgG in the re-ChIP, showed that NF-B p65 binds, together with either KDM4A or KDM4C, to Wdr5 gene loci 24 h after stimulation ( Figure 4F ). Furthermore, treatment with the NF-B inhibitor Bay 11-7082 results in reduced Wdr5 mRNA ( Figure 4G ) and increased H3K9me2/me3 levels at some Wdr5 loci ( Figure 4H ) in stimulated B cells. Together, these results indicate that NF-B, together with KDM4A and KDM4C, is needed for the transcription of Wdr5 in B cells primed with Tfh cellmimicking signals.
WDR5 regulates B cell proliferation and activates cyclindependent kinase inhibitors (CDKNs)
We next depleted WDR5 by transfecting three independent siRNAs or siRNA-pools against Wdr5 into purified Figure 5C and Supplementary Figure S3C ). These findings are similar to the effects of KDM4A and KDM4C knockdown in stimulated B cells. To determine whether WDR5 is a critical downstream target of KDM4A and KDM4C, we reintroduced WDR5 via a lentiviral vector ( Figure 5D ) in stimulated B cells that were also transfected with siKDM4A-pools and siKDM4C-pools. As compared with cells transfected with siCtrl group, KDM4A and KDM4C depletion and transduction with control lentiviral vector not only decreased WDR5 mRNA in mouse splenic B cells stimulated with Tfh-mimicking signals ( Figure 5D ) but also enhanced the induction of CD69 and CD86 activation markers ( Figure  5E -G) and increased proliferation ( Figure 5H ). Moreover, reintroduction of WDR5 abrogated the enhanced induction of activation markers ( Figure 5E -G) and proliferation (Figure 5H ) in KDM4A and KDM4C depleted cells. These results suggest that WDR5 is an important target of KDM4A and KDM4C in the control of B cell activation and proliferation. However, overexpression of WDR5 alone did not significantly alter B cell activation and proliferation primed by Tfh-cell mimicking signals ( Figure 5D −H). We next dissected the mechanistic insights of the function of WDR5 in activated B cells. We re-visited the cDNA microarray data of KDM4A or KDM4C depleted B cells that were stimulated with Tfh cell-mimicking signals (Supplementary Table S3 ). Gene Ontology (GO) analysis of these differentially expressed genes that are affected by knockdown of KDM4A or KDM4C revealed that 'cell cycle' was among the top 10 enriched GO categories 72 h after stimulation (Supplementary Figure S4) . Among the genes in this category, we noticed that the expression of several CDKNs is closely regulated by KDM4C and KDM4C ( Figure 6A) . CDKNs arrest the cell cycle by interfering with the interaction between cyclins and cyclin-dependent kinases (CDKs) that promote cell cycle progression (31) . Using RT-qPCR array and RT-qPCR, we further showed that the expression of these CDKNs was concomitantly down-regulated in WDR5 knockdown splenic B cells ( Figure 6B and C) . In particular, Cdkn2a and Cdkn3 levels were accordingly reduced when KDM4A or KDM4C was depleted ( Figure  6C ). Moreover, reduced Cdkn2a and Cdkn3 expression is associated with decreased H3K4me3 levels at their gene loci in WDR5-depleted B cells ( Figure 6D ). H3K4me3 levels at Cdkn2a and Cdkn3 loci were consistently reduced in KDM4A or KDM4C knockdown B cells, and depletion of both in stimulated B cells caused more significantly reduced H3K4me3 levels at Cdkn2a and Cdkn3 loci ( Figure 6E ). We further found that the expression of Cdkn2a, Cdkn2c and Cdkn3 was reduced after inhibition of NF-B activity by BAY-117082 treatment, and their expression was recovered after reintroduction of WDR5 ( Figure 6F ). To further evaluate the potential function of KDM4A/KDM4C in immune responses in vivo, we immunized Prdm1 EYFP/+ reporter mice with T cell-dependent antigen NP-keyhole limpet hemocyanin (NP-KLH). These mice carry the en- Figure  6H ). Taken together, our data revealed that NF-B participated KDM4A/KDM4C and WDR5 epigenetic cascades program the initiation of cell cycle arrest genes following exposure to Tfh cell-derived signals.
Abnormal expression of KDM4A and KDM4C is found in SLE B cells
In parallel, we investigated whether up-regulation of KDM4A and KDM4C also occurred in human B cells responding to Tfh cell-mimicking signals. Moreover, we sought to examine whether their expression is dysregulated in B cells isolated from human SLE patients, which exhibit hyperreactivity. We compared the expression of KDM4A and KDM4C in peripheral blood B cells isolated from healthy donors and SLE patients and subsequently stimulated with IL-21, anti-CD40, B-cell activating factor (BAFF), and anti-IgM. Compared with normal human B cells, SLE B cells indeed showed enhanced B cell activation, as characterized by elevated induction of CD69 and augmented proliferation after stimulation (Supplementary Figure S5A ulation ( Figure 7A and B) were consistent with their upregulation in mouse B cells primed with Tfh cell-mimicking signals. It is noted that KDM4A and KDM4C levels were significantly reduced in the steady state, as well as in the stimulated SLE B cells, as compared with normal B cells ( Figure 7A and B) . We then sought to determine whether the epigenetic changes could be observed in SLE B cells. It is noted that, the activated normal human B cells exhibited a broad reduction of H3K9me2 and H3K9me3 ( Figure 7C ). By contrast, the levels of H3K9me2 and H3K9me3 in stimulated SLE B cells did not appear to significantly change ( Figure 7C ). The expression of WDR5 mRNA as well as several CDKNs, including CDKN2A and CDKN3, in stimulated B cells, was reduced in stimulated SLE B cells as compared with that in stimulated normal B cells ( Figure 7D 
DISCUSSION
Although it has been reported that the global levels of H3K9me2/me3 and H3K4me2 are all up-regulated at 72 h after LPS and IL-4 stimulation in B cells (34) , the overall changes in histone modification in response to Tfh cellmimicking signals in B cells are still unclear. In this study, we show the global reduction of H3K9me2/me3 in B cells responding to Tfh cell-mimicking signals, but not LPS stimulation. Methylation of H3K9 has been implicated in heterochromatin formation and gene silencing. Trimethylation on H3K9 is added by HMTs such as SUV39H1, and removed by the KDM4 family (35) . Different HMTs have distinct target loci; for example, SUV39h1 in mouse cells is enriched in major satellite pericentric repeats (36) . We observed that Suv39h1 mRNA is increased initially in ac- Figure S1A and E) . Instead, we observed changes in the expression of the KDM4 family, particularly KDM4A and KDM4C, in both activated mouse and human B cells. The roles of KDM4 in cancer and its potential application as a therapeutic target have previously been reported (37, 38) . Both KDM4A and KDM4C are known to be important in development, such as in mouse embryonic stem cells (9, 39) . KDM4C has been shown to slow adipogenesis by attenuating the activity of the nuclear receptor PPAR␥ (40) . It has also been reported that KDM4C interacts with KDM1A to collaboratively regulate the expression of androgen receptordependent genes (41) . Here, we found that both KDM4A
and KDM4C are induced following B cells exposed to Tfhcell mimicking signals. The mechanism contributing to the induction of KDM4A and KDM4C awaits further elucidation. We think that KDM4A and KDM4C induction is independent of NF-B activity because treatment with a NF-B inhibitor did not seem to alter their expression (Figure 3D) . In addition to being transcriptionally regulated, KDM4A or KDM4C activity can be modulated by interacting partners. Inositol hexakisphosphate kinase 1 has been shown to interact with KDM4C and affect its association with chromatin (42) . It has been shown that the PI3K pathway regulates KDM4A localization and subsequent activity (43) . Therefore, it is also possible that the activities of KDM4A and KDM4C in the present setting may be affected by their interacting partners. To further understand the tissue-specificity of KDM4A/KDM4C targets, we analyzed the previously published ChIP-seq data of KDM4A and KDM4C targets in mouse acute myeloid leukemia cells (AML cells, accession number GSE81300) (24) . Our combined bioinformatics analyses identified 335 genes significantly bound by KDM4A in AML cells, of which 28.4% overlapped with our KDM4A targets in B cells, and 359 genes significantly bound by KDM4C, of which 28% were commonly found in our KDM4C targets in B cells (Supplementary Figure S6A and Supplementary Table S2, sheets 2  and 3) . Among the various histone modifications that occur, H3K4me3 is considered to be a marker of actively transcribed genes (2, 44) . Methylation of H3K4 is mediated by methyltransferases such as WDR5-dependent COMPASSfamily proteins (30) . Here, we observed that WDR5 is upregulated by a KDM4A/KDM4C/NF-B complex in stimulated B cells. Although global H3K4me3 levels are transiently increased 12 h after stimulation, this trend did not seem to be associated with the kinetics of WDR5 induction. We suspect that induction of WDR5 may not significantly alter global H3K4me3 levels in this context. Indeed, the correlation between H3K4me3 levels and the status of transcribed genes is ambiguous. High resolution ChIP-seq data show a significant enrichment of H3K4me3 between −200 bp and +50 bp of the activated genes, consistent with polymerase II binding profiles (2) . It has also been reported that H3K4me3 islands are found to be associated with 59% of silent promoters (2) .
To understand the whole picture of the regulatory complex of KDM4A and KDM4C, we applied ChIP-seq data of KDM4A and KDM4C binding profiles to compare the consensus binding of transcription factors. One transcription factor sharing a similar binding motif with KDM4A and KDM4C is NF-B p65. Interestingly, our co-IP data show that KDM4A/KDM4C forms a complex with NF-B at 24 h after stimulation but not at 48 h. We suspect that additional interacting partners or additional posttranslational modifications may account for this temporal interaction. To comprehend the relationship between KDM4A/KDM4C and RELA, we compared the binding targets of NF-B and KDM4A or KDM4C by using a published RELA ChIP-seq data from GEO database (accession number GSE36099) (22) . Bioinformatics analyses revealed that 84 and 82 RELA binding genes were commonly found in our KDM4A and KDM4C ChIP-seq data, respectively. Particularly, RELA-bound genes were found in 34.1% of KDM4A and 31.0% of KDM4C targets, respectively, and Wdr5 was one of them (Supplementary Figure  S6A and Supplementary Table S4 ). However, while we show the binding of KDM4A/KDM4C to the NF-B RELA subunit, we cannot exclude that other NF-B subunits are involved because it has been demonstrated that RELA is dispensable for GC formation and affinity maturation in vivo (45) .
Non-canonical NF-B negatively regulates type 1 interferon by attenuating RELA/KDM4A complex binding at the Ifnb promoter after viral infection (46) . However, the genome-wide targets of KDM4A and RELA in viral infection were not revealed. In another scenario, KDM4A cooperates with SRF/myocardin, the master transcription factor that controls cardiogenesis and differentiation of smooth muscle cell lineages, to influence the expression of Fhl1 through its H3K9me2/me3 specific demethylase activity (47) . These studies show the importance of associations between KDM4 family members and vital transcription factors for gene expression regulation in physiological and infectious states. Our results reveal the importance of the temporal interaction of KDM4A/KDM4C/NF-B in the control of induction of critical regulators in B cell activation and proliferation.
Alignments of various histone marks have shown that H3K9me2/me3 signals are higher in silent genes than active genes across a ±10 kb region surrounding the transcription start site (2) . Our data show that KDM4A and KDM4C bind −12 kb upstream of WDR5. WDR5 has previously been shown to associate with the undifferentiated state of pluripotent stem cells (48) , to be essential for vertebrate development (49) , to be required for the recruitment of the transcription factor Myc to chromatin in tumorigenesis (50) , and to play a role in cell cycle regulation in mixedlineage leukemia (51) . Inhibition of the activity of WDR5 by small molecules in mixed-lineage leukemia cells reduced cell proliferation and induced apoptosis (51) . Prior to our present study, the regulation of WDR5 was largely unknown, and the targets of WDR5 and the detailed mode of action of WDR5 in B cell activation are still unknown. Nevertheless, we show for the first time in this study that WDR5 expression is controlled by a KDM4A/KDM4C/NF-B complex and that several Cdkns are positively regulated by WDR5.
In this study, we found that, in response to Tfh cell-mimicking signals in vitro, the initiation of KDM4A/KDM4C/NF-B epigenetic cascade may serve as the gatekeeper that regulates the cell cycle progression of activated B cells. Supporting this notion, our cDNA microarray data of the changes in gene expression in Tfh-signal primed B cells with KDM4A, KDM4C or WDR5 knockdown revealed that Cdkn2a and Cdkn3 may be involved. Cdkn3 has been reported to contribute to the maintenance of T cell homeostasis during infection (52) , but its role in B cell activation has not been shown. CDKN2A (p16) is an important tumor suppressor gene that inhibits the assembly of CDKs by binding to CDK4 or CDK6, and CDKN2A mutations are associated with tumorigenesis (53) . Of note, Cdkn2a is located in the susceptible locus of Balb/c mice for plasmacytoma (54) . Cdkn2a expression also facilitates terminal differentiation of human adult brain tissue (55) . These reports combined with our findings imply that KDM4A/KDM4C/NF-B-mediated induction of Cdkn2 may have additional roles in favor of terminal differentiation of plasma cells, although it requires further experiments to demonstrate this hypothesis.
It is known that Tfh cells promote the expansion and differentiation of GC B cells. We here report a regulatory epigenetic pathway in activated B cells primed by Tfh cellmimicking signals in vitro that guide the proper activation and proliferation of B cells. We demonstrated that, following stimulation, KDM4A and KDM4C are induced and temporally collaborate with NF-B to regulate a panel of target genes. In particular, we found that WDR5 is a critical direct target of the KDM4A/KDM4C/NF-B complex. Upon its activation, WDR5 then establishes the H3K4 methyltransferase complex at the promoter of several CDKNs, including Cdkn2a and Cdkn3, facilitating their expression and thereby modulating cell proliferation. Our results also suggest a new pathogenic alteration in SLE B cells that are inert in terms of the initiation of KDM4A/KDM4C epigenetic pathway after encountering Tfh signals. KDM4A, KDM4C and WDR5, as well as CDKNs are dysregulated in stimulated SLE B cells, supporting the hypothesis that some abnormal expression of histone modifiers is present in patients with SLE (56) .
